Mode d’action moléculaire des fibrates
J. Soc. Biol., 193 1 (1999) 67-75
Publié en ligne : 2017-04-04
Article cité par
La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Article cité :
Citations de cet article :
Gemfibrozil Induces Anemia, Leukopenia and Reduces Hematopoietic Stem Cells via PPAR-α in Mice
Gabriel Rufino Estrela, Adriano Cleis Arruda, Heron Fernandes Vieira Torquato, Leandro Ceotto Freitas-Lima, Mauro Sérgio Perilhão, Frederick Wasinski, Alexandre Budu, Ricardo Ambrósio Fock, Edgar Julian Paredes-Gamero and Ronaldo Carvalho AraujoInternational Journal of Molecular Sciences 21 (14) 5050 (2020)
https://doi.org/10.3390/ijms21145050
Fenofibrate impairs liver function and structure more pronounced in old than young rats
Adrian Zubrzycki, Agata Wrońska, Anna Kotulak-Chrząszcz, Piotr Mieczysław Wierzbicki and Zbigniew KmiećArchives of Gerontology and Geriatrics 91 104244 (2020)
https://doi.org/10.1016/j.archger.2020.104244
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases
Shizuya Yamashita, Daisaku Masuda and Yuji MatsuzawaCurrent Atherosclerosis Reports 22 (1) (2020)
https://doi.org/10.1007/s11883-020-0823-5
Synthesis of Best-Seller Drugs
Ruben Vardanyan and Victor HrubySynthesis of Best-Seller Drugs 285 (2016)
https://doi.org/10.1016/B978-0-12-411492-0.00020-1
Metabolomics
Jessica E. Montanez, Jeffrey M. Peters, Jared B. Correll, Frank J. Gonzalez and Andrew D. PattersonToxicologic Pathology 41 (2) 410 (2013)
https://doi.org/10.1177/0192623312466960
Stimulation of rat liver branched-chain alpha-keto acid dehydrogenase activity by low doses of bezafibrate
Malgorzata Knapik-CzajkaToxicology 306 101 (2013)
https://doi.org/10.1016/j.tox.2013.02.011
Peroxisome Proliferator-Activated Receptors (PPARs)
Fabio Lannutti, Alessandro Marrone and Nazzareno ReMethods in Molecular Biology, Peroxisome Proliferator-Activated Receptors (PPARs) 952 229 (2013)
https://doi.org/10.1007/978-1-62703-155-4_17
A key role for lipoic acid synthesis duringPlasmodiumliver stage development
Brie Falkard, T. R. Santha Kumar, Leonie-Sophie Hecht, et al.Cellular Microbiology 15 (9) 1585 (2013)
https://doi.org/10.1111/cmi.12137
Prediction of the PPARα agonism of fibrates by combined MM–docking approaches
Fabio Lannutti, Alessandro Marrone and Nazzareno ReJournal of Molecular Graphics and Modelling 29 (6) 865 (2011)
https://doi.org/10.1016/j.jmgm.2011.02.002
The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARα
Hirosuke Danno, Kiyo-aki Ishii, Yoshimi Nakagawa, et al.Biochemical and Biophysical Research Communications 391 (2) 1222 (2010)
https://doi.org/10.1016/j.bbrc.2009.12.046
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Maryam Rakhshandehroo, Bianca Knoch, Michael Müller and Sander KerstenPPAR Research 2010 1 (2010)
https://doi.org/10.1155/2010/612089
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor α Agonists
Letizia Giampietro, Alessandra Ammazzalorso, Antonella Giancristofaro, et al.Journal of Medicinal Chemistry 52 (20) 6224 (2009)
https://doi.org/10.1021/jm900878u
Citrus polymethoxylated flavones improve lipid and glucose homeostasis and modulate adipocytokines in fructose-induced insulin resistant hamsters
Rachel W. Li, Andre G. Theriault, Karen Au, et al.Life Sciences 79 (4) 365 (2006)
https://doi.org/10.1016/j.lfs.2006.01.023
PPAR-α activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats
Xueying Zhao, Jeffrey E. Quigley, Jianghe Yuan, et al.American Journal of Physiology-Heart and Circulatory Physiology 290 (6) H2187 (2006)
https://doi.org/10.1152/ajpheart.00937.2005
Design of new potent hypolipidemic agents with the synergistic structural properties of α-asarone and fibrates
Clara Zúñiga, Leticia Garduño, María del Carmen Cruz, et al.Drug Development Research 64 (1) 28 (2005)
https://doi.org/10.1002/ddr.10418
Potent hypolipidemic activity of mimetic amides of fibrates based on the 2-methoxy-4-(2-propenyl)phenoxyacetic scaffold
Dolores Hernández, Pablo Bernal, Adriana Cruz, et al.Drug Development Research 61 (1) 19 (2004)
https://doi.org/10.1002/ddr.10333
Fenofibrate lowers adiposity and corrects metabolic abnormalities, but only partially restores endothelial function in dietary obese rats
Ebrahim K. Naderali, Sameer Fatani and Gareth WilliamsAtherosclerosis 177 (2) 307 (2004)
https://doi.org/10.1016/j.atherosclerosis.2004.07.029
Apolipoprotein A-II, HDL metabolism and atherosclerosis
Anne Tailleux, Patrick Duriez, Jean-Charles Fruchart and Véronique ClaveyAtherosclerosis 164 (1) 1 (2002)
https://doi.org/10.1016/S0021-9150(01)00751-1
Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis
Helen Vosper, Guennadi A Khoudoli, Tracey L Graham and Colin N.A PalmerPharmacology & Therapeutics 95 (1) 47 (2002)
https://doi.org/10.1016/S0163-7258(02)00232-2